Close Menu

The US Food and Drug Administration approved biotech firm Geron's application to conduct a clinical trial of a human embryonic stem cell therapy. The decision came days after President Obama was inaugurated though Geron and FDA representatives say the timing is coincidental.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Springer Nature announces €9,500 fee to make papers open-access in Nature and its family of journals.

An early SARS-CoV-2 alteration may have enabled it to spread more easily, according to the New York Times.

Librarians have concluded that notebooks that belonged to Charles Darwin that were thought to have been lost were actually likely stolen, CNN reports.

In PNAS this week: ultrarare variants contribute to aging-related hearing loss, telomeres of cells infected with herpesvirus, and more.